NCT00594932 Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis Status COMPLETED Phase PHASE1/PHASE2
NCT00583362 A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02 Status COMPLETED Phase PHASE2
NCT00556192 Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus Status COMPLETED Phase PHASE2
NCT00541749 A Study of rhuMAb IFNalpha in Adults With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1
NCT00539838 A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN) Status TERMINATED Phase PHASE3
NCT00527176 Pulse Corticosteroid Therapy and Effect on Brain Water Diffusivity Status UNKNOWN Phase N/A
NCT00522002 CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study Status COMPLETED Phase N/A
NCT00519363 Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors Status COMPLETED Phase PHASE1/PHASE2
NCT00508898 The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria Status WITHDRAWN Phase PHASE4
NCT00504244 Myfortic Versus Azathioprine in Systemic Lupus Erythematosus Status TERMINATED Phase PHASE3
NCT00479622 Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus Status TERMINATED Phase PHASE1